Dr. Salvatore Mandalà is a chartered biologist with many years of experience in the field of microbiology. He started working with Microbiology in 2003 during his internship as undergraduate student. After graduation, he gets a short contract from University of Palermo to optimize a model for antibiotic production in Actinobacteria and then he gets a Ph.D. fellowship continuing his work on Streptomyces spp. a Gram positive bacteria, used mainly as a model for drugs production and morphological and physiological differentiation. During this period, he had the opportunity to work in some other laboratories abroad in Europe: in Salamanca (Spain), thanks to a six months “Leonardo Da Vinci” fellowship founded by the EU, at the “Biozentrum” in Basel (Switzerland) and also in Lund University (Sweden), for three months thanks to a “FEMS Research Fellowship”. Dr. Mandalà discussed his Ph.D. thesis titled “Study of the sapA gene function in Streptomyces coelicolor and Streptomyces lividans”, in March 2010. Working with Actinobacteria and Streptomyces spp. gave him a deep knowledge of Molecular Microbiology, Molecular Biology and Microbial Genetics. He had also the title of “Doctor Europaeus” eventually. Once finished his Ph.D. he won a position for the 5 years High Specialization School in Clinical Microbiology and Virology (European Board Internship) of the University of Siena (Operative base) and University Pisa (Administrative base). The title of his specialization thesis was: “The BD MAX™ automated system for carbapenemase gene identification from rectal swab”, the final Viva to defend his thesis was held in Pisa on July the 24th 2015. Meanwhile, during these five years, he also started working for U.P.M.C. Italy at Is.Me.T.T. (I.R.C.C.S.) hospital in Palermo, as a Clinical Research Associate, as Senior Research project designer for fund raising and as clinical microbiologist at Laboratory of Clinical Pathology, Microbiology and Virology and also for the Ri.MED Foundation as Training Coordinator. During this span of time, he actively worked also as a clinical microbiologist.
New drugs discovery from microorganisms; Antibiotic resistance, particularly on Enterobacteriaceae with a deep interest not only in nosocomial infections but also on any putative reservoir they could use for spreading to human, like for instance animal or food samples and also Microbiota and Enteric Bacteria as a therapeutic target.